Patents and publications

Algenis has a portfolio of 61 patents, grouped in 7 families. All 61 patents have been awarded.

The company is constantly researching for its patent portfolio to grow and thus continue to deliver value to the state-of-the-art technologies that are being developed and that seek to become a treatment solution for diverse pathologies.